PRDX2 and lung carcinoma: In lung cancer cells, S-nitrosylation of the H2O2-eliminating enzyme Prdx2 (peroxiredoxin-2) led to increases in H2O2 levels, which activated AMPK, followed by phosphorylation of SIRT1 and, thus, abolishment of its deacetylating activity.